FDA: Most Sponsors’ PMRs on Time, But Reporting Lags Behind

Drug Industry Daily
A A
Most drugmakers are fulfilling their postmarketing study commitments, but many are not meeting their deadlines for annual status reports, the FDA said.

To View This Article:

Login

Subscribe To Drug Industry Daily